1 Smallpox Vaccine Market Overview 1.1 Product Overview and Scope of Smallpox Vaccine 1.2 Smallpox Vaccine Segment by Type 1.2.1 Global Smallpox Vaccine Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 First Generation 1.2.3 Second Generation 1.2.4 Third Generation 1.3 Smallpox Vaccine Segment by Application 1.3.1 Smallpox Vaccine Sales Comparison by Application: (2021-2027) 1.3.2 Government Hospital And Program 1.3.3 Private Hospitals / Clinicss 1.4 Global Smallpox Vaccine Market Size Estimates and Forecasts 1.4.1 Global Smallpox Vaccine Revenue 2016-2027 1.4.2 Global Smallpox Vaccine Sales 2016-2027 1.4.3 Smallpox Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027 2 Smallpox Vaccine Market Competition by Manufacturers 2.1 Global Smallpox Vaccine Sales Market Share by Manufacturers (2016-2021) 2.2 Global Smallpox Vaccine Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Smallpox Vaccine Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Smallpox Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Smallpox Vaccine Market Competitive Situation and Trends 2.5.1 Smallpox Vaccine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Smallpox Vaccine Players Market Share by Revenue 2.5.3 Global Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Smallpox Vaccine Retrospective Market Scenario by Region 3.1 Global Smallpox Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Smallpox Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Smallpox Vaccine Market Facts & Figures by Country 3.3.1 North America Smallpox Vaccine Sales by Country 3.3.2 North America Smallpox Vaccine Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Smallpox Vaccine Market Facts & Figures by Country 3.4.1 Europe Smallpox Vaccine Sales by Country 3.4.2 Europe Smallpox Vaccine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Smallpox Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Smallpox Vaccine Sales by Region 3.5.2 Asia Pacific Smallpox Vaccine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Smallpox Vaccine Market Facts & Figures by Country 3.6.1 Latin America Smallpox Vaccine Sales by Country 3.6.2 Latin America Smallpox Vaccine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Smallpox Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Smallpox Vaccine Sales by Country 3.7.2 Middle East and Africa Smallpox Vaccine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Smallpox Vaccine Historic Market Analysis by Type 4.1 Global Smallpox Vaccine Sales Market Share by Type (2016-2021) 4.2 Global Smallpox Vaccine Revenue Market Share by Type (2016-2021) 4.3 Global Smallpox Vaccine Price by Type (2016-2021) 5 Global Smallpox Vaccine Historic Market Analysis by Application 5.1 Global Smallpox Vaccine Sales Market Share by Application (2016-2021) 5.2 Global Smallpox Vaccine Revenue Market Share by Application (2016-2021) 5.3 Global Smallpox Vaccine Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Bavarian Nordic 6.1.1 Bavarian Nordic Corporation Information 6.1.2 Bavarian Nordic Description and Business Overview 6.1.3 Bavarian Nordic Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Bavarian Nordic Product Portfolio 6.1.5 Bavarian Nordic Recent Developments/Updates 6.2 CEL-SCI 6.2.1 CEL-SCI Corporation Information 6.2.2 CEL-SCI Description and Business Overview 6.2.3 CEL-SCI Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.2.4 CEL-SCI Product Portfolio 6.2.5 CEL-SCI Recent Developments/Updates 6.3 Chimerix 6.3.1 Chimerix Corporation Information 6.3.2 Chimerix Description and Business Overview 6.3.3 Chimerix Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Chimerix Product Portfolio 6.3.5 Chimerix Recent Developments/Updates 6.4 EpiVax 6.4.1 EpiVax Corporation Information 6.4.2 EpiVax Description and Business Overview 6.4.3 EpiVax Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 EpiVax Product Portfolio 6.4.5 EpiVax Recent Developments/Updates 6.5 Nanotherapeutics 6.5.1 Nanotherapeutics Corporation Information 6.5.2 Nanotherapeutics Description and Business Overview 6.5.3 Nanotherapeutics Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Nanotherapeutics Product Portfolio 6.5.5 Nanotherapeutics Recent Developments/Updates 6.6 Oncovir 6.6.1 Oncovir Corporation Information 6.6.2 Oncovir Description and Business Overview 6.6.3 Oncovir Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Oncovir Product Portfolio 6.6.5 Oncovir Recent Developments/Updates 6.7 SIGA Technologies 6.6.1 SIGA Technologies Corporation Information 6.6.2 SIGA Technologies Description and Business Overview 6.6.3 SIGA Technologies Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 SIGA Technologies Product Portfolio 6.7.5 SIGA Technologies Recent Developments/Updates 6.8 Symphogen 6.8.1 Symphogen Corporation Information 6.8.2 Symphogen Description and Business Overview 6.8.3 Symphogen Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Symphogen Product Portfolio 6.8.5 Symphogen Recent Developments/Updates 6.9 TapImmune 6.9.1 TapImmune Corporation Information 6.9.2 TapImmune Description and Business Overview 6.9.3 TapImmune Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.9.4 TapImmune Product Portfolio 6.9.5 TapImmune Recent Developments/Updates 6.10 Tonix Pharmaceuticals Holding 6.10.1 Tonix Pharmaceuticals Holding Corporation Information 6.10.2 Tonix Pharmaceuticals Holding Description and Business Overview 6.10.3 Tonix Pharmaceuticals Holding Smallpox Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Tonix Pharmaceuticals Holding Product Portfolio 6.10.5 Tonix Pharmaceuticals Holding Recent Developments/Updates 7 Smallpox Vaccine Manufacturing Cost Analysis 7.1 Smallpox Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Smallpox Vaccine 7.4 Smallpox Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Smallpox Vaccine Distributors List 8.3 Smallpox Vaccine Customers 9 Smallpox Vaccine Market Dynamics 9.1 Smallpox Vaccine Industry Trends 9.2 Smallpox Vaccine Growth Drivers 9.3 Smallpox Vaccine Market Challenges 9.4 Smallpox Vaccine Market Restraints 10 Global Market Forecast 10.1 Smallpox Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Smallpox Vaccine by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Smallpox Vaccine by Type (2022-2027) 10.2 Smallpox Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Smallpox Vaccine by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Smallpox Vaccine by Application (2022-2027) 10.3 Smallpox Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Smallpox Vaccine by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Smallpox Vaccine by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Smallpox Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Smallpox Vaccine Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Smallpox Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Smallpox Vaccine Covered in This Study Table 5. Global Smallpox Vaccine Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Smallpox Vaccine Sales Share by Manufacturers (2016-2021) Table 7. Global Smallpox Vaccine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Smallpox Vaccine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Smallpox Vaccine Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Smallpox Vaccine Manufacturing Sites and Area Served Table 11. Manufacturers Smallpox Vaccine Product Type Table 12. Global Smallpox Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Smallpox Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Smallpox Vaccine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Smallpox Vaccine Sales by Region (2016-2021) & (K Units) Table 16. Global Smallpox Vaccine Sales Market Share by Region (2016-2021) Table 17. Global Smallpox Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Smallpox Vaccine Sales by Country (2016-2021) & (K Units) Table 19. North America Smallpox Vaccine Sales Market Share by Country (2016-2021) Table 20. North America Smallpox Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Smallpox Vaccine Revenue Market Share by Country (2016-2021) Table 22. Europe Smallpox Vaccine Sales by Country (2016-2021) & (K Units) Table 23. Europe Smallpox Vaccine Sales Market Share by Country (2016-2021) Table 24. Europe Smallpox Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Smallpox Vaccine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Smallpox Vaccine Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Smallpox Vaccine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Smallpox Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Smallpox Vaccine Revenue Market Share by Region (2016-2021) Table 30. Latin America Smallpox Vaccine Sales by Country (2016-2021) & (K Units) Table 31. Latin America Smallpox Vaccine Sales Market Share by Country (2016-2021) Table 32. Latin America Smallpox Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Smallpox Vaccine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Smallpox Vaccine Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Smallpox Vaccine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Smallpox Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Smallpox Vaccine Revenue Market Share by Country (2016-2021) Table 38. Global Smallpox Vaccine Sales (K Units) by Type (2016-2021) Table 39. Global Smallpox Vaccine Sales Market Share by Type (2016-2021) Table 40. Global Smallpox Vaccine Revenue (Million US$) by Type (2016-2021) Table 41. Global Smallpox Vaccine Revenue Share by Type (2016-2021) Table 42. Global Smallpox Vaccine Price (USD/Unit) by Type (2016-2021) Table 43. Global Smallpox Vaccine Sales (K Units) by Application (2016-2021) Table 44. Global Smallpox Vaccine Sales Market Share by Application (2016-2021) Table 45. Global Smallpox Vaccine Revenue (Million US$) by Application (2016-2021) Table 46. Global Smallpox Vaccine Revenue Share by Application (2016-2021) Table 47. Global Smallpox Vaccine Price (USD/Unit) by Application (2016-2021) Table 48. Bavarian Nordic Corporation Information Table 49. Bavarian Nordic Description and Business Overview Table 50. Bavarian Nordic Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Bavarian Nordic Smallpox Vaccine Product Table 52. Bavarian Nordic Recent Developments/Updates Table 53. CEL-SCI Corporation Information Table 54. CEL-SCI Description and Business Overview Table 55. CEL-SCI Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. CEL-SCI Smallpox Vaccine Product Table 57. CEL-SCI Recent Developments/Updates Table 58. Chimerix Corporation Information Table 59. Chimerix Description and Business Overview Table 60. Chimerix Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Chimerix Smallpox Vaccine Product Table 62. Chimerix Recent Developments/Updates Table 63. EpiVax Corporation Information Table 64. EpiVax Description and Business Overview Table 65. EpiVax Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. EpiVax Smallpox Vaccine Product Table 67. EpiVax Recent Developments/Updates Table 68. Nanotherapeutics Corporation Information Table 69. Nanotherapeutics Description and Business Overview Table 70. Nanotherapeutics Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Nanotherapeutics Smallpox Vaccine Product Table 72. Nanotherapeutics Recent Developments/Updates Table 73. Oncovir Corporation Information Table 74. Oncovir Description and Business Overview Table 75. Oncovir Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Oncovir Smallpox Vaccine Product Table 77. Oncovir Recent Developments/Updates Table 78. SIGA Technologies Corporation Information Table 79. SIGA Technologies Description and Business Overview Table 80. SIGA Technologies Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. SIGA Technologies Smallpox Vaccine Product Table 82. SIGA Technologies Recent Developments/Updates Table 83. Symphogen Corporation Information Table 84. Symphogen Description and Business Overview Table 85. Symphogen Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Symphogen Smallpox Vaccine Product Table 87. Symphogen Recent Developments/Updates Table 88. TapImmune Corporation Information Table 89. TapImmune Description and Business Overview Table 90. TapImmune Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. TapImmune Smallpox Vaccine Product Table 92. TapImmune Recent Developments/Updates Table 93. Tonix Pharmaceuticals Holding Corporation Information Table 94. Tonix Pharmaceuticals Holding Description and Business Overview Table 95. Tonix Pharmaceuticals Holding Smallpox Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Tonix Pharmaceuticals Holding Smallpox Vaccine Product Table 97. Tonix Pharmaceuticals Holding Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Smallpox Vaccine Distributors List Table 101. Smallpox Vaccine Customers List Table 102. Smallpox Vaccine Market Trends Table 103. Smallpox Vaccine Growth Drivers Table 104. Smallpox Vaccine Market Restraints Table 105. Global Smallpox Vaccine Sales Forecast by Type (2022-2027) & (K Units) Table 106. Global Smallpox Vaccine Sales Market Share Forecast by Type (2022-2027) Table 107. Global Smallpox Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 108. Global Smallpox Vaccine Revenue Market Share Forecast by Type (2022-2027) Table 109. Global Smallpox Vaccine Sales Forecast by Application (2022-2027) & (K Units) Table 110. Global Smallpox Vaccine Sales Market Share Forecast by Application (2022-2027) Table 111. Global Smallpox Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 112. Global Smallpox Vaccine Revenue Market Share Forecast by Application (2022-2027) Table 113. Global Smallpox Vaccine Sales Forecast by Region (2022-2027) & (K Units) Table 114. Global Smallpox Vaccine Sales Market Share Forecast by Region (2022-2027) Table 115. Global Smallpox Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 116. Global Smallpox Vaccine Revenue Market Share Forecast by Region (2022-2027) Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Smallpox Vaccine Figure 2. Global Smallpox Vaccine Market Share by Type in 2020 & 2027 Figure 3. First Generation Product Picture Figure 4. Second Generation Product Picture Figure 5. Third Generation Product Picture Figure 6. Global Smallpox Vaccine Market Share by Application in 2020 & 2027 Figure 7. Government Hospital And Program Figure 8. Private Hospitals / Clinicss Figure 9. Global Smallpox Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Smallpox Vaccine Market Size 2016-2027 (US$ Million) Figure 11. Global Smallpox Vaccine Sales 2016-2027 (K Units) Figure 12. Global Smallpox Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Smallpox Vaccine Sales Share by Manufacturers in 2020 Figure 14. Global Smallpox Vaccine Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Smallpox Vaccine Players: Market Share by Revenue in 2020 Figure 16. Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Smallpox Vaccine Sales Market Share by Region (2016-2021) Figure 18. Global Smallpox Vaccine Sales Market Share by Region in 2020 Figure 19. Global Smallpox Vaccine Revenue Market Share by Region (2016-2021) Figure 20. Global Smallpox Vaccine Revenue Market Share by Region in 2020 Figure 21. U.S. Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Smallpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Smallpox Vaccine by Type (2016-2021) Figure 46. Sales Market Share of Smallpox Vaccine by Application (2016-2021) Figure 47. Sales Market Share of Smallpox Vaccine by Application in 2020 Figure 48. Revenue Share of Smallpox Vaccine by Application (2016-2021) Figure 49. Revenue Share of Smallpox Vaccine by Application in 2020 Figure 50. Manufacturing Cost Structure of Smallpox Vaccine Figure 51. Manufacturing Process Analysis of Smallpox Vaccine Figure 52. Smallpox Vaccine Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Bavarian Nordic CEL-SCI Chimerix EpiVax Nanotherapeutics Oncovir SIGA Technologies Symphogen TapImmune Tonix Pharmaceuticals Holding